February 17, 2021

Mydecine Speaker Series: Part III-Drug Development

IndiaProduction

IndiaProduction

Recommended Reports

Gaucher Disease Type III Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Apolipoprotein C III (APOC3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Antithrombin III (ATIII or SERPINC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

D3 Dopamine Receptor (Dopamine D3 Receptor or DRD3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

View All

More

Medical Technology UK 2023

International congress on pediatrics neonatal and nursing care, Prague

Outsourcing in Clinical Trials: Medical Devices USA 2023

Outsourcing in Clinical Trials West Coast (& device stream) 2023